Actively Recruiting
Left Atrial Posterior Wall and Mitral Isthmus PF Ablation in Non-Paroxysmal AF Patients
Led by Charles University, Czech Republic · Updated on 2025-11-21
50
Participants Needed
1
Research Sites
47 weeks
Total Duration
On this page
Sponsors
C
Charles University, Czech Republic
Lead Sponsor
B
Biosense Webster, Inc.
Collaborating Sponsor
AI-Summary
What this Trial Is About
An observational study evaluating efficacy and safety of the Varipulse catheter in pulsed-field ablation of atrial fibrillation
CONDITIONS
Official Title
Left Atrial Posterior Wall and Mitral Isthmus PF Ablation in Non-Paroxysmal AF Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Non-paroxysmal atrial fibrillation
- Indication for catheter ablation according to current guidelines
- Willingness to sign informed consent
You will not qualify if you...
- Hematological disorders associated with spontaneous hemolysis
- Chronic kidney disease stage 3 or worse
- Previous left atrial ablation using pulsed-field or radiofrequency energy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospital Kralovske Vinohrady
Prague, Czechia
Actively Recruiting
Research Team
P
Pavel Osmancik, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here